Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine and Rituximab in Follicular Lymphoma (BRiF)
NCT02423837Phase 3Unknown
- Sponsor
- National Medical Research Center for Hematology
- Start
- Dec 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bendamustine, rituximab in follicular lymphoma (FL), sponsored by National Medical Research Center for Hematology. Status: unknown.
02
Drugs
bendamustinerituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT02423837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02423837.